{"entity":{"type":"insider","cik":"0001901321","url":"/insider/0001901321","json_url":"/insider/0001901321.json","name":"Milnes Alistair","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":13,"first":"2023-01-05","last":"2026-01-06","span_basis":"filed_date"},"name_variants":[{"name":"Milnes Alistair","source":"filing","n_filings":13,"first_seen":"2023-01-05","last_seen":"2026-01-06"}],"transactions":[{"id":6206655,"accession":"0001901321-26-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001901321-26-000002","line_url":"/filing/0001901321-26-000002#line-3","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3416.0,"shares_display":"3,416","price_per_share":6.46,"price_display":"6.46","price_state":"stated","total_value":22067.36,"total_display":"22,067.36","total_whole":"22,067","shares_owned_after":136717.0,"shares_owned_after_display":"136,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-06","scope":"insider"},{"id":6206651,"accession":"0001901321-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001901321-26-000002","line_url":"/filing/0001901321-26-000002#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3244.0,"shares_display":"3,244","price_per_share":6.8,"price_display":"6.80","price_state":"stated","total_value":22059.2,"total_display":"22,059.20","total_whole":"22,059","shares_owned_after":140133.0,"shares_owned_after_display":"140,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-06","scope":"insider"},{"id":4645063,"accession":"0001901321-25-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001901321-25-000003","line_url":"/filing/0001901321-25-000003#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":978.0,"shares_display":"978","price_per_share":8.41,"price_display":"8.41","price_state":"stated","total_value":8224.98,"total_display":"8,224.98","total_whole":"8,225","shares_owned_after":93377.0,"shares_owned_after_display":"93,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-06","scope":"insider"},{"id":4645053,"accession":"0001901321-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001901321-25-000003","line_url":"/filing/0001901321-25-000003#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1147.0,"shares_display":"1,147","price_per_share":8.4,"price_display":"8.40","price_state":"stated","total_value":9634.8,"total_display":"9,634.80","total_whole":"9,635","shares_owned_after":94355.0,"shares_owned_after_display":"94,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-06","scope":"insider"},{"id":5081216,"accession":"0001415889-25-019426","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-019426","line_url":"/filing/0001415889-25-019426#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":966.0,"shares_display":"966","price_per_share":7.44,"price_display":"7.44","price_state":"stated","total_value":7187.04,"total_display":"7,187.04","total_whole":"7,187","shares_owned_after":95502.0,"shares_owned_after_display":"95,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-03","filed_date":"2025-07-07","scope":"insider"},{"id":5081211,"accession":"0001415889-25-019426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-019426","line_url":"/filing/0001415889-25-019426#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1149.0,"shares_display":"1,149","price_per_share":7.09,"price_display":"7.09","price_state":"stated","total_value":8146.41,"total_display":"8,146.41","total_whole":"8,146","shares_owned_after":96468.0,"shares_owned_after_display":"96,468","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-02","filed_date":"2025-07-07","scope":"insider"},{"id":4952170,"accession":"0001415889-25-010242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-010242","line_url":"/filing/0001415889-25-010242#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1038.0,"shares_display":"1,038","price_per_share":7.48,"price_display":"7.48","price_state":"stated","total_value":7764.24,"total_display":"7,764.24","total_whole":"7,764","shares_owned_after":97617.0,"shares_owned_after_display":"97,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-03","filed_date":"2025-04-04","scope":"insider"},{"id":4952165,"accession":"0001415889-25-010242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-010242","line_url":"/filing/0001415889-25-010242#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1133.0,"shares_display":"1,133","price_per_share":8.02,"price_display":"8.02","price_state":"stated","total_value":9086.66,"total_display":"9,086.66","total_whole":"9,087","shares_owned_after":98655.0,"shares_owned_after_display":"98,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-02","filed_date":"2025-04-04","scope":"insider"},{"id":5002559,"accession":"0001415889-25-000924","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-000924","line_url":"/filing/0001415889-25-000924#line-3","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":936.0,"shares_display":"936","price_per_share":14.75,"price_display":"14.75","price_state":"stated","total_value":13806.0,"total_display":"13,806.00","total_whole":"13,806","shares_owned_after":99788.0,"shares_owned_after_display":"99,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-03","filed_date":"2025-01-06","scope":"insider"},{"id":5002553,"accession":"0001415889-25-000924","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-000924","line_url":"/filing/0001415889-25-000924#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4578.0,"shares_display":"4,578","price_per_share":14.09,"price_display":"14.09","price_state":"stated","total_value":64504.02,"total_display":"64,504.02","total_whole":"64,504","shares_owned_after":100724.0,"shares_owned_after_display":"100,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-06","scope":"insider"},{"id":2711838,"accession":"0001415889-24-024769","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-024769","line_url":"/filing/0001415889-24-024769#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":972.0,"shares_display":"972","price_per_share":22.26,"price_display":"22.26","price_state":"stated","total_value":21636.72,"total_display":"21,636.72","total_whole":"21,637","shares_owned_after":70302.0,"shares_owned_after_display":"70,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-03","filed_date":"2024-10-04","scope":"insider"},{"id":2132271,"accession":"0001415889-24-019383","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019383","line_url":"/filing/0001415889-24-019383#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":967.0,"shares_display":"967","price_per_share":19.64,"price_display":"19.64","price_state":"stated","total_value":18991.88,"total_display":"18,991.88","total_whole":"18,992","shares_owned_after":71274.0,"shares_owned_after_display":"71,274","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-03","filed_date":"2024-07-08","scope":"insider"},{"id":2805875,"accession":"0001415889-24-010416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-010416","line_url":"/filing/0001415889-24-010416#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":955.0,"shares_display":"955","price_per_share":23.81,"price_display":"23.81","price_state":"stated","total_value":22738.55,"total_display":"22,738.55","total_whole":"22,739","shares_owned_after":72241.0,"shares_owned_after_display":"72,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-03","filed_date":"2024-04-05","scope":"insider"},{"id":2118742,"accession":"0001209191-24-000877","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-000877","line_url":"/filing/0001209191-24-000877#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2643.0,"shares_display":"2,643","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":46252.5,"total_display":"46,252.50","total_whole":"46,253","shares_owned_after":73196.0,"shares_owned_after_display":"73,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-04","scope":"insider"},{"id":8116972,"accession":"0001209191-23-052251","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-052251","line_url":"/filing/0001209191-23-052251#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":442.0,"shares_display":"442","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":8840.0,"total_display":"8,840.00","total_whole":"8,840","shares_owned_after":36839.0,"shares_owned_after_display":"36,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-03","filed_date":"2023-10-05","scope":"insider"},{"id":8608155,"accession":"0001209191-23-041573","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-041573","line_url":"/filing/0001209191-23-041573#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":451.0,"shares_display":"451","price_per_share":25.1,"price_display":"25.10","price_state":"stated","total_value":11320.1,"total_display":"11,320.10","total_whole":"11,320","shares_owned_after":37281.0,"shares_owned_after_display":"37,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-06","scope":"insider"},{"id":7994973,"accession":"0001209191-23-023349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023349","line_url":"/filing/0001209191-23-023349#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":447.0,"shares_display":"447","price_per_share":21.11,"price_display":"21.11","price_state":"stated","total_value":9436.17,"total_display":"9,436.17","total_whole":"9,436","shares_owned_after":37732.0,"shares_owned_after_display":"37,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":7916419,"accession":"0001209191-23-002205","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002205","line_url":"/filing/0001209191-23-002205#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001901321","owner_name":"Milnes Alistair","owner_display_name":"Milnes Alistair","owner_url":"/insider/0001901321","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1801.0,"shares_display":"1,801","price_per_share":29.06,"price_display":"29.06","price_state":"stated","total_value":52337.06,"total_display":"52,337.06","total_whole":"52,337","shares_owned_after":38179.0,"shares_owned_after_display":"38,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001761612","name":"BICYCLE THERAPEUTICS PLC","url":"/issuer/0001761612","role":"Officer (CHIEF OPERATING OFFICER)","n_filings":13,"first_seen":"2023-01-05","last_seen":"2026-01-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001901321","retrieved_at":"2026-08-26T18:06:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}